Beyond genetics and lifestyle, the gut microbiome is now emerging as an important factor in cancer progression and treatment response. This raises an important question: could understanding and targeting this ecosystem transform the way we treat cancer?
Bifidobacteria are increasingly studied as a marker of gut health across a lifetime. In this interview, microbiome researcher Sudarshan Shetty explains what shapes them, how they change with age, and what diet can do.
Crohn’s disease is an inflammatory bowel disease linked to an imbalance in the gut microbiome. Now, researchers at McMaster University have found in mice a way to target and 'turn off' only the bad gut bacteria using specially trained, precision viruses. This breakthrough paves the way for treatments tailored to each patient.
Stay tuned to our latest news
Food 4 Gut Health news
World Diet Initiative: Mapping heritage diets is a race against time
28 Oct 2026by Konstantina Zafeiropoulou
As processed, Western-style diets spread worldwide, traditional dietary patterns are disappearing. Emerging research shows how rapidly dietary transitions can reshape immune and metabolic responses, while the World Diet Initiative is racing to document heritage diets before they are lost.
One in four adults experience digestive symptoms that impact quality of life
15 Jun 2026by Andreu Prados
Digestive symptoms with an impact on quality of life (QoL) affect one in four adults in the general population worldwide who do not qualify for a diagnosis of a Disorder of Gut-Brain Interaction (DGBI). Recent research suggests this ‘sub-diagnostic’ group demands additional investigation and might benefit from targeted interventions, including dietary interventions.
Research & Practice news
When IBD is in remission but symptoms persist: a new consensus on IBS-like symptoms
2 Nov 2026by Manon Oliero
Around one in four patients with IBD may continue to experience IBS-like symptoms despite objectively documented remission. A new international consensus provides clinicians with a framework for recognizing and managing this challenging clinical picture.
A gut microbiome signature could identify risk of Parkinson’s disease years before symptoms appear
19 Oct 2026by Hervé Blottière
New findings reveal the gut microbiome evolves gradually from healthy people, across those with genetic risk of Parkinson’s disease to patients who are symptomatic.
Gut microbial trimethylamine directly targets IRAK4, revealing an unexpected link between the microbiome, inflammation and glycemic control
5 Oct 2026by Giovana Martucelli
A new study sheds light on how gut microbiota-derived metabolites can influence host immune and metabolic pathways. Focusing on trimethylamine (TMA) and IRAK4 signaling, the findings help clarify the mechanisms linking microbial metabolism with metabolic inflammation and glycemic regulation.
